Track Ginkgo Bioworks Holdings's other current assets ($17M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Ginkgo Bioworks Holdings (DNA) currently reports a other current assets of $17M as of March 2026. That compares with $20M in the prior-year period — down 18.4% year over year. Use the charts on this page to explore Ginkgo Bioworks Holdings's other current assets history and peer comparisons.
Ginkgo Bioworks Holdings's other current assets decreased from $20M to $17M — a 18.4% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Ginkgo Bioworks Holdings reported $17M in other current assets as of March 2026. That compares with $20M in the prior-year period — down 18.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current other current assets of $17M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Ginkgo Bioworks Holdings, and consider following DNA for alerts when major investors trade the stock.
Ginkgo Bioworks Holdings is classified in the Healthcare sector. On other current assets, it currently shows $17M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing DNA with unrelated industries.